Detection of rare prostate cancer cells in human urine offers prospect of non-invasive diagnosis

Two molecular cytology approaches, (i) time-gated immunoluminescence assay (TGiA) and (ii) Raman-active immunolabeling assay (RiA), have been developed to detect prostate cancer (PCa) cells in urine from five prostate cancer patients. For TGiA, PCa cells stained by a biocompatible europium chelate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayyadi, Nima, Justiniano, Irene, Wang, Yan, Zheng, Xianlin, Zhang, Wei, Jiang, Lianmei, Polikarpov, Dmitry M., Willows, Robert D., Gillatt, David, Campbell, Douglas, Walsh, Bradley J., Yuan, Jingli, Lu, Yiqing, Packer, Nicolle H., Wang, Yuling, Piper, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630382/
https://www.ncbi.nlm.nih.gov/pubmed/36323734
http://dx.doi.org/10.1038/s41598-022-21656-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630382/
https://www.ncbi.nlm.nih.gov/pubmed/36323734
http://dx.doi.org/10.1038/s41598-022-21656-9

Ejemplares similares